Jerry,
All the technical conferences generally have a date at which the Abstracts for the conferences are revealed. If it's a late breaking Abstract, it may be nearly at the conference date, but still before it. We've always learned before the conference that we won't be presenting there. Next weekends conference isn't such a technical conference, it's possible that TLD could be issued and presented there, but I don't believe it would be considered peer reviewed information.
Last year it was clear that Dr. Liau submitted placeholder Abstracts at SNO and other conferences, so it had been planned to present there. Clearly the data wasn't received from the contractors in time to do so, so the presentations were withdrawn. At some point after that time the company decided on a Journal rather than a technical conference, only they can know the reason. There is no doubt that this was a very complex trial, I suspect that the more comprehensive presentation possible in a Journal was the reason.
I still expect two things to happen before a Journal publication occurs, one is the update to Clinical Trials, stating the modified goals, the second is a TLD statement. It may only be a matter of hours before the Journal, but the Journal will refer to the goals, they should be the revised goals which ought to be in Clinical Trials, they are in the European versions.
Gary
News 
Market Data 
Discover 
AI
